⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SEDICO Pharmaceutical Company and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SEDICO Pharmaceutical Company
↗6th of October City, Egypt
SEDICO Pharmaceutical Company is a pioneering Egyptian biopharmaceutical manufacturer established in 1990. The company specializes in a wide range of pharmaceutical and biotechnology products, including insulin, growth hormones, and oncology therapies, operating out of its facilities in the 6th of October City, Egypt.
SEDICO maintains a robust manufacturing portfolio of over 180-280 products across 14 therapeutic groups, including cardiovascular, gastroenterology, and respiratory treatments. The company is recognized for its commitment to cGMP regulations and has expanded its reach significantly, exporting products to various markets across the Middle East, Africa, and Europe.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Biotechnology and Generic Pharmaceuticals
SIZE & FINANCIALS
Employees:1001-5000
Revenue:~$50M-$100M (Estimated from ~2.7B EGP)
Founded:1989
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biotechnology (Insulin/Growth Hormone), Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:MSD (Production under license), F-Trenka (Production under license)
COMPETITION
Position:Leader
LINKS
Website:sedicopharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SEDICO Pharmaceutical Company. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.